MST Continus 10 mg

MST Continus 10 mg contains the active ingredient Morphine sulfate in a prolonged-release tablet formulation. It is a prescription-only opioid medicine used for the management of severe, long-term pain when opioid treatment is considered appropriate by a healthcare professional.

The prolonged-release formulation is designed to release morphine gradually over an extended period, providing sustained pain relief when taken as prescribed. It is intended for around-the-clock pain management rather than the rapid treatment of breakthrough pain.

MST Continus 10 mg should only be used under the supervision of a qualified healthcare professional. The dosage is individualized based on the patient’s condition, previous opioid use, and response to treatment. Tablets should be swallowed whole and must not be crushed, chewed, or broken, as doing so can release the medicine too quickly and increase the risk of serious adverse effects.

Common side effects may include drowsiness, constipation, nausea, dizziness, and vomiting. More serious risks include respiratory depression, dependence, misuse, addiction, overdose, and withdrawal symptoms if treatment is stopped abruptly. Patients should avoid alcohol and follow their prescriber’s instructions regarding driving or operating machinery.

This medicine may not be suitable for everyone. Patients should inform their healthcare provider about any existing medical conditions, current medications, pregnancy or breastfeeding status, and any history of substance use disorder before starting treatment.

Always use MST Continus 10 mg exactly as prescribed and consult your healthcare professional if you have questions about its safe and appropriate use.